MSN - AP World http://syn2.thecanadianpress.com:8080/mrss/feed/fcf7391a2f354311807f0501c16bde6a MSN - AP World Copyright © 2010-2018 The Canadian Press. All rights reserved. http://www.rssboard.org/rss-specification Mon, 24 Jan 2022 23:57:17 +0000 FDA panel debates booster for single-dose vaccine http://syn2.thecanadianpress.com:8080/mrss/feed/fcf7391a2f354311807f0501c16bde6a/4ec8c1d3261a49cd8a38e4403d21249c U.S. health advisers are meeting to tackle who needs boosters of Johnson & Johnson's single-shot COVID-19 vaccine and when. J&J wants its vaccine recipients to be eligible for another shot, citing increased protection after a second dose. (Oct. 15) 4ec8c1d3261a49cd8a38e4403d21249c Fri, 15 Oct 2021 15:01:16 +0000 SHOTLIST:RESTRICTION SUMMARY:U.S. FOOD AND DRUG ADMINISTRATIONLocation unknown - 15 October 2021++EDIT STARTS ON SOUNDBITE++1. SOUNDBITE (English) Dr. Penny Heaton, Johnson & Johnson:"We want to provide optimal protection against COVID, and we know that a booster dose will do that. It will increase efficacy against severe disease, it will increase efficacy against all symptomatic COVID and it will increase the breadth of the immune response against variants. The booster may be given at least two months after the initial vaccination, but our data suggest that boosting at six months will induce an even stronger immune response."++WHITE FLASH++2. SOUNDBITE (English) Dr. Johan Van Hoof, Johnson & Johnson:"Where we see that in general population we would look into giving it all at six months to optimally, to have optimal benefit immunologically from that booster, if we see specific situations like people in an environment where there's an extremely high transmission rate of new variants, health care workers, all the people, people like elderly with co-morbidities, there we might think that it might be beneficial to also give that booster earlier."++ENDS ON SOUNDBITE++STORYLINE:U.S. health advisers are meeting to tackle who needs boosters of Johnson & Johnson's single-shot COVID-19 vaccine and when. Advisers to the Food and Drug Administration on Friday also will examine data suggesting that booster of a competing brand might provide better protection. The national booster campaign kicked off last month with a third dose of the Pfizer vaccine offered to certain high-risk groups at least six months after their initial vaccination. On Thursday, the same FDA panel recommended a lower-dose Moderna booster for similar people. For J&J, the panel will consider if another dose is needed as early as two months."We want to provide optimal protection against COVID, and we know that a booster dose will do that," said J&J's Dr. Penny Heaton. "It will increase efficacy against severe disease, it will increase efficacy against all symptomatic COVID and it will increase the breadth of the immune response against variants."___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.===========================================================Clients are reminded: (i) to check the terms of their licence agreements for use of content outside news programming and that further advice and assistance can be obtained from the AP Archive on: Tel +44 (0) 20 7482 7482 Email: info@aparchive.com(ii) they should check with the applicable collecting society in their Territory regarding the clearance of any sound recording or performance included within the AP Television News service (iii) they have editorial responsibility for the use of all and any content included within the AP Television News service and for libel, privacy, compliance and third party rights applicable to their Territory. U.S. health advisers are meeting to tackle who needs boosters of Johnson & Johnson's single-shot COVID-19 vaccine and when. J&J wants its vaccine recipients to be eligible for another shot, citing increased protection after a second dose. (Oct. 15) FDA panel debates booster for single-dose vaccine